Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ≥65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kohei Shitara, Toshihiko Doi, Hisashi Hosaka, Peter C. Thuss-Patience, Armando Santoro, Paula Jiménez-Fonseca, Federico Longo, Ozgur Ozyilkan, Irfan Cicin, David Park, Mohamedtaki Abdulaziz Tejani, Aziz Zaanan, Domenico Bilancia, Carles Pericay, Mustafa Ozguroglu, MARIA ALSINA, Lukas Makris, Sandra McGuigan, David H. Ilson
Institutions: National Cancer Center Hospital East, Gunma Prefectural Cancer Center, Charité – Universitätsmedizin Berlin, IRCCS Humanitas Research Hospital, Hospital Universitario Central de Asturias, Hospital Universitario Ramón y Cajal, Başkent University, Trakya University, St. Jude Medical Center, University of Rochester Medicine, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Ouest, Corporació Sanitària Parc Taulí, Istanbul University-Cerrahpaşa, Istanbul University, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Taiho Oncology (United States), Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2945079968